Hussain S, Schwartz J M, Friedman S A, Chua S N
Am Heart J. 1978 Jul;96(1):31-6. doi: 10.1016/0002-8703(78)90123-0.
The course of essential thrombocythemia has been observed in ten patients, ages 46 to 83, of whom nine were followed for a period of 4 months to 9 years. In contrast to the experience with essential thrombocythemia recorded in the literature, manifestations of arterial thrombosis were far more common than hemorrhage. In six of the ten patients, the presenting complaints were ascribable to incipient gangrene of the toes and several of these patients additionally developed occlusion of tibial and larger arteries while under our observation. All patients with incipient gangrene showed marked clinical improvement accompanying busulfan-induced reduction and normalization of the platelet count. Relapses in five patients after 2 to 87 months responded well to retreatment with busulfan. No patient has shown evolution to another myeloproliferative disorder. Essential thrombocythemia should be considered in the differential diagnosis of occlusive arterial disease.
对10例年龄在46至83岁之间的原发性血小板增多症患者的病程进行了观察,其中9例患者的随访时间为4个月至9年。与文献中记录的原发性血小板增多症的经验相反,动脉血栓形成的表现远比出血更为常见。在这10例患者中的6例中,主要症状归因于脚趾早期坏疽,并且在我们的观察期间,其中一些患者还出现了胫动脉和较大动脉的闭塞。所有有早期坏疽的患者在白消安诱导血小板计数降低并恢复正常后,临床症状均有明显改善。5例患者在2至87个月后复发,再次使用白消安治疗效果良好。没有患者发展为另一种骨髓增殖性疾病。在闭塞性动脉疾病的鉴别诊断中应考虑原发性血小板增多症。